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2. Abstract 
Objective: Sex differences in disease susceptibility might be explained by sexual dimorphism in 
hypothalamic-pituitary-adrenal axis activity, which has been postulated to emerge during puberty. 
However, studies conducted thus far lacked an assessment of Tanner pubertal stage. This study 
aimed to assess the contribution of pubertal development to sexual dimorphism in cortisol 
production and metabolism.
Methods: Participants (n=218), were enrolled from a population-based Netherlands Twin Register. At 
the ages of 9, 12 and 17 years Tanner pubertal stage was assessed, and early-morning urine samples 
were collected. Cortisol metabolites were measured with GC-MS/MS, and ratios were calculated, 
representing cortisol metabolism enzyme activities, such as A-ring reductases, 11β-HSDs and CYP3A4. 
Cortisol production and metabolism parameters were compared between sexes for pre-pubertal 
(Tanner stage 1), early-pubertal (Tanner stage 2-3) and late-pubertal (Tanner stage 4-5) stages. 
Results: Cortisol metabolite excretion rate decreased with pubertal maturation in both sexes, but did 
not significantly differ between sexes at any pubertal stage, although in girls a considerable decrease 
was observed between early- and late-pubertal stage (P<0.001). A-ring reductase activity was similar 
between sexes at pre- and early-pubertal stages, and was lower in girls than in boys at late-pubertal 
stage. Activities of 11β-HSDs were similar between sexes at pre-pubertal stage, and favored 
cortisone in girls at early- and late-pubertal stages. Cytochrome P450 3A4 activity did not differ 
between sexes. 
Conclusions: Prepubertally, sexes were similar in cortisol parameters. During puberty, as compared 
to boys, in girls the activities of A-ring reductases declined and the balance between 11β-HSDs 
progressively favored cortisone. In addition, girls showed a considerable decrease in cortisol 
metabolite excretion rate between early- and late-pubertal stages. Our findings suggest that the 
sexual dimorphism in cortisol may either be explained by rising concentrations of sex steroids or by 
puberty-induced changes in body composition.
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3. Introduction
Males and females differ in their susceptibility to develop specific diseases. While females are more 
likely to develop auto-immune diseases and neuropsychiatric disorders like anxiety and depression, 
males are more susceptible to infectious diseases, and are more likely to engage in violent 
competition (1-3). Moreover, males and females differ in cardiovascular disease susceptibility (4). Sex 
differences in HPA axis settings have been hypothesized to play a role in these differences (5-10). 
Sexual dimorphism in HPA axis activity has been suggested to be already present in early childhood. 
A recent meta-analysis suggested that boys and girls differed in basal HPA axis activity, as assessed by 
salivary cortisol levels. Compared to girls, boys, up to age 8, had higher salivary cortisol levels and 
lower levels beyond this age (11). The timing of this change suggests that sex steroids influence the 
HPA axis. Surprisingly, to the best of our knowledge there are no studies that have reported on HPA 
axis activity across pubertal development. 
HPA axis activity is determined by the net effect of cortisol production and metabolism. Cortisol is 
metabolized by various enzymes (Figure 1). The A-ring reductases (5α- and 5β-reductase), together 
with Cytochrome P (CYP) 3A4, eliminate cortisol from the circulation primarily in the liver (12). The 
11beta-hydroxysteroid dehydrogenase (11β-HSD) isozymes regulate the interconversion between 
cortisol and its inactive metabolite cortisone. 11β-HSD type 1 is mainly expressed in the liver and 
adipose tissue, where it regenerates cortisol, and 11β-HSD type 2 catalyzes the reverse reaction in 
renal epithelial cells.
In adulthood, females were found to have a lower urinary excretion rate of cortisol metabolites than 
males (13-15). This is likely to be attributed to less A-ring reduction in females, resulting in a 
prolonged half-life of cortisol and, hence, enhanced central feedback suppression (14). In contrast, 
CYP3A4 activity is higher in women than in men. However, CYP3A4 is known to eliminate only a small 
proportion of circulating cortisol (16,17). There is controversy as to whether men and women differ 
in the activities of 11β-HSDs (14,18-20). 
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Interaction between gonadal steroids and the metabolism of cortisol has been suggested by several 
studies (21-24). However, there is only one cross-sectional study that has investigated glucocorticoid 
metabolism in children of various ages (18). This study demonstrated that the sex differences in the 
elimination rate of cortisol as observed in adulthood began around age 11-12 y, and were 
attributable to a progressive difference in 5α-reductase activity (being lower in older girls). 
Therefore, sexual dimorphism in cortisol metabolism was postulated to emerge during pubertal 
maturation, suggesting an interplay of adrenal and gonadal axes (18). However, information on 
pubertal stage was not available in that study (18). To the best of our knowledge, a longitudinal 
follow-up study of cortisol metabolism from pre- to post-puberty has never been conducted. The aim 
of this study was to assess the contribution of pubertal development to sexual dimorphism in cortisol 
production and metabolism. 
4. Material and methods
Participants
We conducted a prospective follow-up study and recruited healthy mono- and dizygotic twin pairs 
from the Netherlands Twin Register (NTR), a population-based registry (25,26). Twins born between 
1995 and 1996 were invited to participate in the BrainScale study of cognition, hormones, and brain 
development (27,28). BrainScale is a collaborative project between the NTR of the VU University 
Amsterdam and the University Medical Center Utrecht. Four to eight weeks before the ninth birthday 
of the twins, a letter of invitation was sent to their parents. Following the invitation letter, the 
families were contacted by phone to inquire whether they were willing to participate. At the age of 9 
y, 109 of the invited twin pairs (51%) participated in this study. Eighty-two percent of them 
participated at age 12 y, and 80% participated at age 17 y. Seventy-one percent participated at all 
three occasions. Parents signed informed consent forms for their participating children and for 
themselves. In addition, twins signed their own informed consent forms at the third occasion (i.e., at 
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age 17 y). The current study was approved by the medical ethics committee of the Amsterdam UMC, 
location VUmc.
Participants were physically examined by a researcher for pubertal stage at ages 9 and 12 y. The 
examination was based on secondary sexual characteristics according to Marshall and Tanner, i.e., 
breast stage in girls and genital stage in boys (29,30). Prior to the study, researchers were trained in 
the assessment of pubertal stage. If children felt uncomfortable with physical examination, pubertal 
stage was determined by self-report based on reference images. Of the participants, 100% and 80% 
were physically examined for pubertal stage at the ages of 9 and 12 y, respectively. At age 17 y, 
pubertal stage was always determined by self-report. In addition, at age 17 y information on the 
timing of menarche was ascertained. Previous data showed that the inter-rater agreement of self-
reported data is relatively low, ranging between 49% and 86% in girls, and between 27% and 78% in 
boys, in comparison to researcher-reported data (31-37). Therefore, we classified participants as pre-
pubertal (Tanner stage 1, hereafter referred to as stage A), early-pubertal (Tanner stages 2 and 3, 
hereafter referred to as stage B) or late-pubertal (Tanner stages 4 and 5, hereafter referred to as 
stage C). Girls documenting menarche were classified as late-pubertal, regardless of Tanner stage. 
For self-reported data, our classification system is expected to have an inter-rater agreement of 82% 
in girls and of 75% in boys, based on Danish reference data (31). These numbers are comparable with 
the inter-rater reliability of individual Tanner stages between trained assessors (38). 
Study protocol
Participants were examined at the ages of 9, 12 and 17 years. In the week prior to their study visit, 
subjects collected first voided morning urine samples in tubes provided by us. Participants were 
requested to store the samples in their refrigerator, and to hand them in at the study visit. Samples 
were stored at -20 and then at -80 degrees Celsius. Samples were thawed only once just before 
analysis. 
Laboratory analysis
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The analysis of cortisol metabolites was conducted at the Edinburgh Clinical Research Facility Mass 
Spectrometry Core Laboratory. Glucocorticoid metabolites were measured by gas chromatography-
tandem mass spectrometry (GC-MS/MS) (39). Samples were analyzed in fifteen batches. Creatinine 
concentrations were measured by the Jaffé method (40). The sum of cortisol metabolites divided by 
creatinine concentration was used as an index of cortisol production (cortisol metabolite excretion 
rate). Enzymatic activities were inferred from cortisol metabolite ratios, as depicted in Table 1. 
Higher ratios indicate higher enzymatic activity, except for 11β-HSD type 2 activity (cortisol/cortisone 
ratio).
Statistical analysis
In line with previous analyses in this sample, extreme outliers (>3SD above the phenotypic mean or 
twin pairs with highly discordant outcomes; on average six and one per index, respectively) were 
excluded from the statistical analysis (41). Next, the data were corrected for batch effects by fitting a 
random effects model, in which batch was treated as a random effect (42). 
Statistical modeling 
Our main aim was to determine the effect of pubertal stage on the outcomes. To this end, we 
implemented a discrete-time Markov model, in which we estimated the mean and standard 
deviation of each metabolite conditional on the pubertal stage. In this model, each participant was 
assigned to stage A, B or C. We took into account that a given participant may transition from stage A 
to B or C, and from stage B to stage C between ages 9 and 12 y, and between 12 y and 17 y, 
respectively. The parameters of the Markov model are the probabilities of being in stage A, B or C at 
age 9 y, transition probabilities from age 9 to 12 y, and transition probabilities from age 12 to 17 y. 
Because no 9 y olds were assigned to stage C, and no 17 y olds were assigned to stage A, the Markov 
model includes stages A and B at age 9 y, stages A, B and C at age 12 y, and stages B and C at age 17 
y. Figure 2 depicts the model. In Figure 2, p1 is the probability of being in stage A at age 9 y, q11 and 
q12 are conditional probabilities governing the transition between age 9 and 12 y, and r11 and r21 are 
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conditional probabilities governing the transition between ages 12 and 17 y. For instance, q12 is the 
probability of transitioning from stage A at age 9 y to stage B at age 12 y.
As we expected sex differences in probability of the pubertal stages at age 9 y and in the transition 
probabilities from ages 9 to 12 y and from 12 to 17 y, we allowed these parameter to vary with sex 
(i.e., the probabilities p1, q11, q12, q22, r11, r21 varied with sex). In addition, we allowed for sex 
differences in the means of the metabolites within a given pubertal stage (i.e., the means mA, mB, 
and mC varied with sex). Standard deviations were constrained to be equal over sexes. 
The Markov transition model was implemented in Mplus 6.0 (Muthén and Muthén 2007) (43). The 
parameters were estimated by means of maximum likelihood (ML) estimation. For this study, twins 
were treated as individuals. Therefore, the standard errors, confidence intervals (Cis), and test 
statistics were corrected for family clustering. For all outcomes, means were calculated for girls and 
boys along with their 95% CIs. Differences between sexes were tested and reported by a two-tailed P 
value, whereby a p < 0.05 was considered as statically significant. Given the sample size, correction 
for multiple testing was not conducted. In addition, changes in cortisol parameters were calculated 
during pubertal development for both sexes. 
5. Results
A total of 218 participants (50% females) were included in this study, including 94 monozygotic and 
124 dizygotic twins. The monozygotic twin pairs included 23 male and 24 female pairs. The dizygotic 
twin pairs included 22 male, 21 female and 19 opposite-sex pairs. Participants were tested at 9.1 
[±0.1], 12.2 [±0.3] and 17.2 [±0.2] years of age. In total 542 samples were analyzed, of which 213 
(50% females), 167 (50% females) and 162 (63% females) were obtained at the ages of 9, 12 and 17 
years, respectively. Mean Standard Deviation Score (Z Score) [±SD] body mass index 
(weight(kg)/height(m)2) was 0.14 [± 0.93], 0.45 [± 1.00] and 0.27 [± 1.08] at the ages 9, 12 and 17 y, 
respectively (44). Table 2 displays the characteristics for boys and girls separately at the ages of 9, 12 
and 17yr.
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Pubertal development
The Markov model parameter estimates are shown in Table 3. At age 9 y, as expected, boys were 
more likely to be pre-pubertal than girls (0.944 vs 0.811). At age 12 y, the entire spectrum of pubertal 
stages were observed in both sexes, although in girls puberty was generally more advanced. At age 
17 y, all girls were classified as late-pubertal, while, contrary to expectation, still 20 percent of the 
boys were early-pubertal.
Consequently, sex differences in the transition probabilities from 9 to 12 y and from 12 to 17 y were 
also observed. For instance, the probability of remaining in stage A between the ages 9 and 12 y was 
markedly higher in boys (0.259) than in girls (0.127). The probability of moving from stage A to C 
between 9 and 12 y was higher in girls than in boys (0.282 vs 0.025). 
Sexual dimorphism in cortisol production and metabolism during pubertal development
Table 4 displays the sex-specific means for cortisol metabolite excretion rate and cortisol metabolite 
ratios by pubertal stage. Cortisol metabolite excretion rate did not statistically differ between sexes 
at any stage. The cortisol metabolite ratios were similar between sexes at stage A, but diverged 
during pubertal development. In boys at stages B and C, as compared to girls of the same stage, the 
balance of 11β-HSD activities ((THF+allo-THF)/THE ratio) favored cortisol. At stage B, this difference 
could be partially attributable to a lower 11β-HSD type 2 activity (cortisol/cortisone ratio) in boys. 
Girls at stage C, as compared to boys of the same stage, had lower activities of 5α- (allo-THF/F ratio) 
and 5β-reductases (THE/E ratio). There were no differences in CYP3A4 activity (6-OH cortisol/cortisol 
ratio) between sexes at stages B or C.
Table 5 presents the changes in cortisol metabolite excretion rate and cortisol metabolite ratios 
during pubertal development by sex. In both sexes cortisol metabolite excretion rate decreased with 
pubertal progression, albeit with few differences. In boys cortisol metabolite excretion rate 
decreased between stages A and B, while in girls it decreased considerably between stages B and C. 
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In both sexes between stages B and C the balance of 11β-HSD activities ((THF+allo-THF)/THE) 
changed in the direction of cortisol, which could partially be explained by decreased 11β-HSD type 2 
activity (cortisol/cortisone ratio). In girls the activities of A-ring reductases (ratios of allo-THF/F, 
THF/F and THE/E) increased (with the exception of 5α-reductase activity) between stages A and B, 
and decreased between stages B and C. In boys these parameters did not change during pubertal 
development. In both sexes CYP3A4 activity (6-OH cortisol/cortisol ratio) was stable across pubertal 
development.
6. Discussion 
In this longitudinal study, we have demonstrated that the excretion of cortisol metabolites diverges 
between sexes with advancing pubertal maturation. Therefore, our study suggests that the sexual 
dimorphism in cortisol metabolism that generally starts around the age of 11 y is a hormonally-driven 
process, either directly, by influencing gene expression, or indirectly, by impacting on body 
composition.
Previous studies showed that adult men and women differ in the excretion rate of cortisol 
metabolites, which was higher in males (13,45). Wudy et al. found that these differences emerged 
from the age of 11-12 y (18), suggestive of an important role of gonadal hormones. However, their 
study lacked an assessment of pubertal status. In our study, which included repeated assessment of 
Tanner pubertal stage, we found that the excretion rate of cortisol metabolites decreased 
significantly in girls between early- and late-pubertal stage, suggestive of an effect of pubertal 
development on the excretion rate of cortisol metabolites in girls. In contrast to previous research 
(18), we were not able to detect statistically significant differences in cortisol metabolite excretion 
rate between sexes which might be due to the use of morning instead of 24-hr urine or the relatively 
small sample size. 
Our data provided evidence for a sexual dimorphism in cortisol metabolism, as assessed by ratios 
reflecting the activities of the enzymes involved. We found that with advancing pubertal maturation 
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in females, as compared to males, the balance of 11β-HSDs progressively favored cortisone and the 
proportion of A-ring reduced metabolites was lower, in line with data in adults (13-15,20,45). During 
pubertal maturation levels of sex steroids increase gradually along with the development of 
secondary sexual characteristics (46). Therefore, our findings suggest that sex steroids influence 
cortisol metabolism either directly, e.g., by influencing gene expression, or indirectly, by impacting 
on body composition (47-49).
With advancing pubertal development, differences in body composition emerge between sexes; girls 
gain more mass, and boys acquire more fat-free mass and skeletal mass (50). These differences are 
regulated by endocrine factors, including gonadal steroids and growth hormone (51), in addition to 
genetic and environmental factors. Body composition is strongly associated with HPA axis activity, 
both in adulthood and childhood (52,53), and the observed differences between sexes in cortisol 
parameters that emerge during pubertal development could (partially) be explained by progressive 
differences in body composition. Although males and females did not differ in BMI at any age, 
unfortunately our study lacked a more detailed assessment of body composition.
It is unclear whether the sex differences in cortisol metabolism that we observed, are androgen- or 
estrogen-mediated. A study in adult men showed that testosterone reduced the CRH-stimulated rise 
in serum cortisol, in spite of increased ACTH, suggestive of adrenal hyporesponsiveness (54). 
Evidence for an effect of androgens on glucocorticoid metabolism was provided by other studies (55-
57). It has been demonstrated by multiple studies that women with polycystic ovary syndrome – a 
condition characterized by increased androgen production – had a higher 5α-reductase activity than 
BMI-matched controls (55). However, this may be part of the PCOS trait rather than an effect of 
hyperandrogenism, as their daughters already had a greater 5α-reductase activity, in spite of a 
similar androgen metabolite excretion rate, from early childhood than age-matched controls (56). In 
contrast, experiments in gonadectomized male rats suggested that androgens suppress the 
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expression and/or the activity of hepatic A-ring reductases (57). In addition, the same experiments 
suggested that androgens increase 11β-HSD type 1 in liver and adipose tissue (57). 
Studies in rats and humans suggest that estrogens could also influence glucocorticoid metabolism, 
though findings were contradictory. Several studies in rodents have shown that the expression 
and/or the activity of A-ring reductases and 11β-HSD type 1 was upregulated and downregulated by 
estrogen, respectively (19,22,58-61). In contrast, in humans the activity of these enzymes was 
independent of the phase of the menstrual cycle or, after menopause, use of estrogen replacement 
therapy (14,15,20). 
Our study has several strengths and limitations. The major strength of our study was the long follow-
up period of 8 years, enabling us to assess the contribution of pubertal maturation to sexual 
dimorphism in HPA axis functioning. Moreover, participants were recruited from a population-based 
twin register and the numbers remaining into follow-up were relatively high for an age group that is 
notoriously difficult to engage in longitudinal studies. Another strength is that all measurements 
were performed in the same laboratory at the same time. Samples were frozen as soon as possible, 
and were thawed only once prior to analysis, which enhances stability (62). 
Our study also has its limitations. First, the Brain Scale study was not powered specifically for the 
present study and, hence, a sample size calculation was not performed prior to analysis, which might 
explain our inability to detect differences in cortisol metabolite excretion rate between sexes. 
Second, some limitations related to our outcome should be acknowledged. Enzymatic activities were 
estimated by ratios of metabolites in morning urine, which estimate activity only globally. Since 
cortisol is secreted in a circadian rhythm, a 24h-urine sample would have been preferred. In addition, 
both short- and long-term stability of cortisol production and metabolism are low, which could have 
influenced our results (63,64). Third, a residual age effect could not be excluded. In order to 
distinguish between a residual age effect and the effect of pubertal maturation, a larger sample size 
is warranted. Fourth, Tanner pubertal stages were for an important part assessed by self-report, 
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which might result in misclassification, notably under classification (31). Nevertheless, our approach 
(i.e., classifying according to pre-, early- and late-pubertal stages, and the use of the Markov model) 
is likely to reduce misclassification.
5. Conclusion
With advancing pubertal maturation, sexual dimorphism in cortisol metabolism became increasingly 
manifest, while prepubertally no differences were seen. These difference could emerge from direct 
or indirect effects of sex steroids on cortisol metabolism. 
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Figures
Figure 1 Schematic overview of cortisol metabolism 
 
Abbreviations: THF, tetrahydrocortisol; THE, tetrahydrocortisone; aTHF, allotetrahydrocortisol; 6β-
OH-cortisol, 6β-hydroxy-cortisol; HSD, hydroxysteroid dehydrogenase; CYP, Cytochrome P
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Figure 2 Statistical model: means depending on pubertal stage and sex
 
*A = pre-pubertal (Tanner stage 1), B = early-pubertal (Tanner stage 2-3), C = late-pubertal (Tanner 
stage 4-5) ). p1 is the probability of being in stage A at age 9 y, q11 and q12 are conditional probabilities 
governing the transition between age 9 and 12 y, and r11 and r21 are conditional probabilities 
governing the transition between ages 12 and 17 y.
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Table 1 Summary of outcomes
Parameter Index
(THF + allo-THF + THE + α-cortol + β-cortol + α-cortolone + 
β-cortolone)/ creatinine
Sum of cortisol metabolites (cortisol 
metabolite excretion rate)
allo-THF/F 5α-reductase activity
THF/F 5β-reductase activity (a)
THE/E 5β-reductase activity (b)
F/E 11β-HSD type 2 activity
(THF + allo-THF)/THE Balance of 11β-HSD activities
6β-OH cortisol/F Cytochrome P450 3A4 activity
Abbreviations: THF, tetrahydrocortisol; THE, tetrahydrocortisone, HSD, hydroxysteroid 
dehydrogenase; F, cortisol; E, cortisone
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Table 2 Characteristics of participants
Boys Girls
9yr (n=106) 12yr (n=83) 17yr (n=77) 9yr (n=106) 12yr (n=86) 17yr (n=95)
Length cm 139.2 ± 5.5 151.8 ± 7.2 179.6 ± 6.2 138.2 ± 4.8 152.5 ± 7.2 168.6 ± 6.1
SDS 0.03 ± 0.89 -0.57 ± 0.93 -0.23 ± 0.83 0.06 ± 0.76 -0.60 ± 1.05 -0.10 ± 0.93
Weight kg 31.6 ± 4.3 42.5 ± 8.4 67.3 ± 9.4 31.3 ± 4.6) 43.8 ± 8.4 61.3 ± 8.88
SDS 0.34 ± 0.95 0.38 ± 0.91 0.12 ± 1.03 0.29 ± 0.91 0.05 ± 2.91 0.37 ± 1.09
Body mass index kg/m2 16.2 ± 1.4 18.6 ± 2.0 20.9 ± 2.5 16.4 ± 2.0 18.8 ± 2.9 21.6 ± 3.3
SDS 0.21 ± 0.83 0.58 ± 0.86 0.21 ± 1.03 0.09 ± 1.00 0.32 ± 1.11 0.30 ± 1.13
Tanner stage (%)* A 94 24 0 81 10 0
                        B 6 70 20 19 62 0
                        C 0 5 80 0 28 100
Values represent mean ±SD or %. *Percentage of patients in Tanner stages are based on the 
transition probabilities according our Markov model. A = pre-pubertal (Tanner stage 1), B = early-
pubertal (Tanner stage 2-3), C = late-pubertal (Tanner stage 4-5).
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Table 3 Pubertal development and transition probabilities according our Markov model
Age (y) Pubertal 
development*
Markov 
parameters
Girls Boys 
9 A p1 0.811 0.944
B 1-p1 0.189 0.056
9->12 A->A q11 0.127 0.259
A->B q12 0.592 0.717
A->C 1-q11-q12 0.282 0.025
B->B q22 0.733 0.500
B->C 1-q22 0.267 0.500
12->17 A->B r11 0.000 0.491
A->C 1-r11 1.000 0.509
B->B r21 0.000 0.110
B->C 1-r21 1.000 0.890
C->C 1 1.000 1.000
*A = pre-pubertal (Tanner stage 1), B = early-pubertal (Tanner stage 2-3), C = late-pubertal (Tanner 
stage 4-5)
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Table 4 Cortisol metabolite excretion rate and cortisol metabolite ratios by pubertal stage
Parameter Pubertal 
stage* 
Mean girls (95% CI) Mean boys (95% CI) Variances Sex 
difference
P value
Effect size
Cohen’s D
Cortisol metabolite A 0.581 (0.533-0.629) 0.571 (0.511-0.631) 0.047 0.777 0.046
excretion rate B 0.577 (0.522-0.631) 0.512 (0.446-0.579) 0.047 0.108 0.300
C 0.448 (0.407-0.489) 0.487 (0.411-0.563) 0.056 0.400 0.165
5α-reductase A 8.982 (8.087-9.876) 9.405 (8.158-10.653) 24.048 0.576 0.086
activity B 9.909 (8.832-10.987) 8.255 (6.784-9.726) 21.623 0.064 0.356
allo-THF/F C 5.504 (4.724-6.284) 8.558 (7.135-9.981) 19.815 <0.001 0.686
5β-reductase A 9.164 (8.388-9.939) 10.195 (9.014-11.377) 20.976 0.151 0.225
activity (a) B 11.116 (10.413-11.820) 11.367 (9.809-13.223) 29.161 0.791 0.046
THF/F C 9.792 (9.096-10.487) 10.729 (9.453-12.006) 15.494 0.227 0.238
5β-reductase A 27.101 (25.358-28.845) 27.409 (25.140-29.678) 70.990 0.823 0.037
activity (b) B 31.517 (28.929-34.106) 29.465 (25.960-32.969) 132.215 0.335 0.178
THE/E C 26.096 (24.404-27.787) 30.468 (26.861-34.076) 123.162 0.046 0.394
11β-HSD type 2 A 0.896 (0.846-0.946) 0.872 (0.799-0.945) 0.100 0.593 0.076
activity B 0.772 (0.688-0.855) 0.915 (0.809-1.022) 0.106 0.027 0.439
F/E C 1.264 (1.168-1.359) 1.242 (1.102-1.382) 0.217 0.796 0.047
Balance of 11β-HSD A 0.613 (0.572-0.655) 0.623 (0.572-0.675) 0.035 0.741 0.053
activities B 0.552 (0.497-0.607) 0.640 (0.570-0.711) 0.054 0.040 0.379
(THF + allo-THF)/THE C 0.669 (0.631-0.708) 0.793 (0.716-0.871) 0.056 0.008 0.524
Cytochrome P450 A 1.893 (1.748-2.038) 1.955 (1.734-2.176) 0.630 0.645 0.078
3A4 activity B 1.907 (1.712-2.101) 1.834 (1.560-2.109) 0.910 0.663 0.077
6β-OH cortisol/F C 1.773 (1.606-1.940) 1.859 (1.598-2.120) 0.604 0.590 0.111
*A = pre-pubertal (Tanner stage 1), B = early-pubertal (Tanner stage 2-3), C = late-pubertal (Tanner 
stage 4-5).
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Table 5 Changes in cortisol metabolite excretion rate and cortisol metabolite ratios during pubertal 
development
Parameter Pubertal 
stage* 
Girls
Mean difference (95% CI)
P value Boys
Mean difference (95% CI)
P value
Cortisol metabolite A -> B -0.004 (-0.069 - 0.060) 0.913 -0.059 (-0.160 - -0.012) 0.040
excretion rate B -> C -0.128 (-0.188 - 0.068) <0.001 -0.024 (-0.097 - 0.048) 0.580
5α-reductase A -> B 0.928 (-0.234 - 2.090) 0.189 -1.150 (-2.367 - -1.150) 0.120
activity B -> C -4.406 (-5.703 - -3.109) <0.001 0.303 (-0.945 - -0.303) 0.690
5β-reductase A -> B 1.953 (1.097 - 2.808) <0.001 1.172 (-0.209 - 2.553) 0.163
activity (a) B -> C -1.325 (-2.366 - -0.284) 0.036 -0.638 (-2.113 - 0.837) 0.477
5β-reductase A -> B 4.416 (1.501 - 7.331) 0.013 2.056 (-0.359 - 4.471) 0.161
activity (b) B -> C -5.422 (-8.335 - -2.508) 0.002 1.003 (-2.180 - 4.186) 0.604
11β-HSD type 2 A -> B -0.124 (-0.213 - -0.036) 0.021 0.043 (-0.025 - 0.111) 0.302
activity B -> C 0.492 (0.363 - 0.620) <0.001 0.326 (0.220 - 0.433) <0.001
Balance of 11β-HSD A -> B -0.061 (-0.119 - -0.004) 0.079 0.016 (-0.031 - 0.063) 0.566
activities B -> C 0.117 (0.046 - 0.188) 0.007 0.153 (0.089 - 0.218) <0.001
Cytochrome P450 A -> B 0.013 (-0.205 - 0.232) 0.919 -0.121 (-0.315 - 0.073) 0.304
3A4 activity B -> C -0.134 (-0.400 - 0.133) 0.410 0.025(-0.251 - 0.301) 0.883
*A = pre-pubertal (Tanner stage 1), B = early-pubertal (Tanner stage 2-3), C = late-pubertal (Tanner 
stage 4-5)
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